NIH-funded research R01 grant

Understanding how immune cells respond to different signals

Official title: Characterizing functional states of macrophages via their stimulus-responses

Funded at University of California Los Angeles · NIH-11092249 · Data updated 2026-11-12

This study is looking at how important immune cells called macrophages behave when they receive different signals, which could help us understand their role in conditions like autoimmune diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJune 1, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$695,335
NIH project number5R01AI173214-03
Project IDNIH-11092249 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with autoimmune conditions or those experiencing immune-related issues.

Less likely to help

Patients with non-autoimmune conditions or those not experiencing immune system-related symptoms may not benefit from this research.

What this research studies

This research investigates the behavior of macrophages, which are crucial immune cells that respond to various stimuli in the body. By examining how these cells react to different signals, the study aims to uncover the mechanisms that dictate their responses and how these responses vary depending on the tissue environment. The approach involves advanced single-cell measurements and computational analyses to quantify the specificity and context of macrophage functions. This could lead to a better understanding of immune responses in various conditions, including autoimmune diseases.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of immune responses, potentially leading to improved treatments for autoimmune diseases and other conditions.

How similar studies have gone: Previous research has shown promise in understanding immune cell behavior, but this approach focusing on single-cell responses is relatively novel.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Hoffmann, Alexander — University of California Los Angeles
  • Study coordinator: Hoffmann, Alexander

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.